Orchid Cellmark Names Thomas A. Bologna President and Chief Executive Officer

Princeton, NJ, Mar. 9, 2006 - Orchid Cellmark Inc. (Nasdaq: ORCH), a leading worldwide provider of identity DNA testing services, today announced that its Board of Directors has appointed Thomas A. Bologna as the company’s new president and chief executive officer. Mr. Bologna fills these positions that had been held by Dr. Paul Kelly, who has left the company. Mr. Bologna will also serve as a director of Orchid Cellmark.

Source: Orchid Cellmark